Delaware Law360 provides breaking news and analysis on legal and regulatory issues in Delaware. Coverage includes high-stakes litigation, policy developments, and corporate deals affecting the state.
Sign up for a 7-day FREE trial today!
Latest News in Delaware
-
October 23, 2026
Eli Lilly and Teva on Friday sparred over whether a new trial should be held in Massachusetts federal court over the validity of patents related to Teva's migraine drug Ajovy after the Federal Circuit reversed the Boston court's judgment that favored Eli Lilly.
-
October 23, 2026
Microsoft Corp.'s $250 million settlement of stockholder claims stemming from its $75.4 billion acquisition of Activision Blizzard Inc. won Delaware Chancery Court approval Friday, as the chancellor rejected an investment fund's attempt to preserve a separate federal securities suit and awarded $60 million in attorney fees.
-
October 23, 2026
IQVIA Holdings Inc. should have brought its poaching suit against four former employees accused of defecting to a competitor in Delaware court under a forum selection clause in their employment contracts, a North Carolina Business Court judge ruled Thursday in dismissing the case.
-
October 23, 2026
Vanda Pharmaceuticals and Alembic Pharmaceuticals notified a Delaware federal judge Friday that they have settled a patent dispute over Alembic's planned generic version of Vanda's schizophrenia drug Fanapt.
-
October 23, 2026
Attorneys general for 20 states and the District of Columbia urged the U.S. Supreme Court to take up a challenge to the validity of "Texas Two-Step" bankruptcies, telling the high court a Fourth Circuit ruling in an asbestos liability case threatens the ability of states to exercise their sovereign power to enforce their own laws.
See more Delaware news